Heartware (HTWR) Sees Q4 Revenue of $68M

Go back to Heartware (HTWR) Sees Q4 Revenue of $68M

JPMorgan Downgrades Heartware International (HTWR) to Neutral

January 12, 2016 11:06 AM UTC

JPMorgan earlier downgraded Heartware International (NASDAQ: HTWR) from Overweight to Neutral with a price target of $39.00 (from $56.00).

For an analyst ratings summary and ratings history on Heartware International click here. For more ratings news on Heartware International click here.

Shares of Heartware International closed at $40.84 yesterday.

... More

Leerink Affirms HeartWare (HTWR) at 'Outperform' Amid Prelim. Q4 Numbers, ENDURANCE Ambitions

January 12, 2016 8:50 AM UTC

Leerink reaffirms HeartWare International, Inc. (Nasdaq: HTWR) at Outperform with a price target of $60 after the company announced preliminary results Monday night.

Analyst Danielle Antalffy commented, ...though yet another MVAD delay appears to be negative, HTWR is submitting its ENDURANCE trial data for... More